Calamos Advisors
BSX icon

Calamos Advisors’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$107M Buy
1,000,279
+30,311
+3% +$3.26M 0.42% 37
2025
Q1
$97.9M Sell
969,968
-57,089
-6% -$5.76M 0.43% 37
2024
Q4
$91.7M Buy
1,027,057
+4,509
+0.4% +$403K 0.38% 44
2024
Q3
$85.7M Sell
1,022,548
-9,364
-0.9% -$785K 0.37% 47
2024
Q2
$79.5M Sell
1,031,912
-50,741
-5% -$3.91M 0.35% 47
2024
Q1
$74.2M Sell
1,082,653
-37,911
-3% -$2.6M 0.35% 58
2023
Q4
$64.8M Sell
1,120,564
-4,939
-0.4% -$286K 0.31% 72
2023
Q3
$59.4M Buy
1,125,503
+2,499
+0.2% +$132K 0.31% 71
2023
Q2
$60.7M Buy
1,123,004
+42,983
+4% +$2.32M 0.3% 71
2023
Q1
$54M Sell
1,080,021
-128,640
-11% -$6.44M 0.26% 94
2022
Q4
$55.9M Sell
1,208,661
-112,498
-9% -$5.21M 0.26% 91
2022
Q3
$51.2M Sell
1,321,159
-3,026
-0.2% -$117K 0.23% 99
2022
Q2
$49.4M Buy
1,324,185
+102,122
+8% +$3.81M 0.21% 107
2022
Q1
$54.1M Buy
1,222,063
+105,492
+9% +$4.67M 0.2% 114
2021
Q4
$47.4M Buy
1,116,571
+21,444
+2% +$911K 0.18% 128
2021
Q3
$47.5M Sell
1,095,127
-55,354
-5% -$2.4M 0.21% 115
2021
Q2
$49.2M Buy
1,150,481
+139,973
+14% +$5.99M 0.22% 102
2021
Q1
$39.1M Buy
1,010,508
+280,323
+38% +$10.8M 0.21% 111
2020
Q4
$26.3M Buy
730,185
+19,257
+3% +$692K 0.15% 162
2020
Q3
$27.2M Sell
710,928
-46,405
-6% -$1.77M 0.17% 141
2020
Q2
$26.6M Sell
757,333
-389,033
-34% -$13.7M 0.19% 144
2020
Q1
$37.4M Buy
1,146,366
+893,345
+353% +$29.1M 0.29% 95
2019
Q4
$11.4M Sell
253,021
-7,913
-3% -$358K 0.06% 299
2019
Q3
$10.6M Buy
+260,934
New +$10.6M 0.06% 306